CN1319344A - 一种运动保健食品 - Google Patents
一种运动保健食品 Download PDFInfo
- Publication number
- CN1319344A CN1319344A CN01112508A CN01112508A CN1319344A CN 1319344 A CN1319344 A CN 1319344A CN 01112508 A CN01112508 A CN 01112508A CN 01112508 A CN01112508 A CN 01112508A CN 1319344 A CN1319344 A CN 1319344A
- Authority
- CN
- China
- Prior art keywords
- ribose
- sports
- weight
- kilograms
- food
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 6
- 230000036541 health Effects 0.000 title description 4
- PYMYPHUHKUWMLA-LMVFSUKVSA-N aldehydo-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 claims abstract description 68
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims abstract description 34
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims abstract description 34
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 239000000463 material Substances 0.000 claims abstract description 7
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 22
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 claims description 21
- JPNFQHLRXBKLKX-UHFFFAOYSA-M sodium;2-(2-sulfosulfanylpropanoylamino)acetate Chemical compound [Na+].OS(=O)(=O)SC(C)C(=O)NCC([O-])=O JPNFQHLRXBKLKX-UHFFFAOYSA-M 0.000 claims description 16
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 14
- 235000013402 health food Nutrition 0.000 claims description 14
- 239000006046 creatine Substances 0.000 claims description 12
- 229960003624 creatine Drugs 0.000 claims description 12
- 239000001103 potassium chloride Substances 0.000 claims description 11
- 235000011164 potassium chloride Nutrition 0.000 claims description 11
- 229960003080 taurine Drugs 0.000 claims description 11
- 239000000576 food coloring agent Substances 0.000 claims description 10
- 159000000000 sodium salts Chemical class 0.000 claims description 8
- 235000000346 sugar Nutrition 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 5
- 235000021055 solid food Nutrition 0.000 claims description 2
- 235000013599 spices Nutrition 0.000 claims description 2
- 238000011084 recovery Methods 0.000 abstract description 7
- 208000007101 Muscle Cramp Diseases 0.000 abstract description 3
- 230000006870 function Effects 0.000 abstract description 3
- 208000017667 Chronic Disease Diseases 0.000 abstract description 2
- 208000031225 myocardial ischemia Diseases 0.000 abstract description 2
- 230000001737 promoting effect Effects 0.000 abstract description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 abstract description 2
- 229930182490 saponin Natural products 0.000 abstract description 2
- 150000007949 saponins Chemical class 0.000 abstract description 2
- 241000208340 Araliaceae Species 0.000 abstract 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 abstract 2
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract 2
- 235000008434 ginseng Nutrition 0.000 abstract 2
- 208000005392 Spasm Diseases 0.000 abstract 1
- 230000003387 muscular Effects 0.000 abstract 1
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 13
- 230000033001 locomotion Effects 0.000 description 12
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 description 10
- XTWYTFMLZFPYCI-UHFFFAOYSA-N Adenosine diphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O XTWYTFMLZFPYCI-UHFFFAOYSA-N 0.000 description 10
- PQGCEDQWHSBAJP-TXICZTDVSA-N 5-O-phosphono-alpha-D-ribofuranosyl diphosphate Chemical compound O[C@H]1[C@@H](O)[C@@H](O[P@](O)(=O)OP(O)(O)=O)O[C@@H]1COP(O)(O)=O PQGCEDQWHSBAJP-TXICZTDVSA-N 0.000 description 5
- 239000006187 pill Substances 0.000 description 5
- 239000002243 precursor Substances 0.000 description 5
- 239000000843 powder Substances 0.000 description 4
- 101800000628 PDH precursor-related peptide Proteins 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000000747 cardiac effect Effects 0.000 description 3
- -1 disodium creatine phosphates Chemical class 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 235000021317 phosphate Nutrition 0.000 description 3
- 229930091371 Fructose Natural products 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 230000000386 athletic effect Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000002360 explosive Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000010627 oxidative phosphorylation Effects 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- XINCECQTMHSORG-UHFFFAOYSA-N Isoamyl isovalerate Chemical compound CC(C)CCOC(=O)CC(C)C XINCECQTMHSORG-UHFFFAOYSA-N 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical class [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000002449 bone cell Anatomy 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- CEYULKASIQJZGP-UHFFFAOYSA-L disodium;2-(carboxymethyl)-2-hydroxybutanedioate Chemical compound [Na+].[Na+].[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O CEYULKASIQJZGP-UHFFFAOYSA-L 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000004108 pentose phosphate pathway Effects 0.000 description 1
- 150000002972 pentoses Chemical class 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000009790 rate-determining step (RDS) Methods 0.000 description 1
- 230000000246 remedial effect Effects 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 235000011496 sports drink Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB01112508XA CN1247109C (zh) | 2001-03-30 | 2001-03-30 | 一种运动保健食品 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB01112508XA CN1247109C (zh) | 2001-03-30 | 2001-03-30 | 一种运动保健食品 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1319344A true CN1319344A (zh) | 2001-10-31 |
CN1247109C CN1247109C (zh) | 2006-03-29 |
Family
ID=4659294
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB01112508XA Expired - Lifetime CN1247109C (zh) | 2001-03-30 | 2001-03-30 | 一种运动保健食品 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1247109C (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101331950B (zh) * | 2008-08-05 | 2012-09-05 | 北京康比特体育科技股份有限公司 | 一种提高运动爆发力的营养补剂 |
CN104939260A (zh) * | 2015-05-28 | 2015-09-30 | 海门品尚医药科技有限公司 | 一种含d-核糖的固体饮料及其制备方法 |
CN104997101A (zh) * | 2015-07-27 | 2015-10-28 | 程柳 | 一种功能饮料 |
CN105614874A (zh) * | 2016-03-11 | 2016-06-01 | 聊城大学 | 一种改善疲劳状态的组合物 |
CN105748551A (zh) * | 2016-03-11 | 2016-07-13 | 聊城大学 | 一种提高缺氧耐受力的组合物 |
CN106579392A (zh) * | 2016-12-23 | 2017-04-26 | 北京康比特体育科技股份有限公司 | 一种缓解延迟性肌肉酸痛的组合物 |
CN115349629A (zh) * | 2022-08-02 | 2022-11-18 | 仙乐健康科技股份有限公司 | 一种激活肌卫星细胞的组合物以及其使用方法 |
-
2001
- 2001-03-30 CN CNB01112508XA patent/CN1247109C/zh not_active Expired - Lifetime
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101331950B (zh) * | 2008-08-05 | 2012-09-05 | 北京康比特体育科技股份有限公司 | 一种提高运动爆发力的营养补剂 |
CN104939260A (zh) * | 2015-05-28 | 2015-09-30 | 海门品尚医药科技有限公司 | 一种含d-核糖的固体饮料及其制备方法 |
CN104997101A (zh) * | 2015-07-27 | 2015-10-28 | 程柳 | 一种功能饮料 |
CN105614874A (zh) * | 2016-03-11 | 2016-06-01 | 聊城大学 | 一种改善疲劳状态的组合物 |
CN105748551A (zh) * | 2016-03-11 | 2016-07-13 | 聊城大学 | 一种提高缺氧耐受力的组合物 |
CN105614874B (zh) * | 2016-03-11 | 2019-04-05 | 海门品尚医药科技有限公司 | 一种改善疲劳状态的组合物 |
CN105748551B (zh) * | 2016-03-11 | 2019-11-19 | 四月(上海)医药科技有限公司 | 一种提高缺氧耐受力的组合物 |
CN106579392A (zh) * | 2016-12-23 | 2017-04-26 | 北京康比特体育科技股份有限公司 | 一种缓解延迟性肌肉酸痛的组合物 |
CN115349629A (zh) * | 2022-08-02 | 2022-11-18 | 仙乐健康科技股份有限公司 | 一种激活肌卫星细胞的组合物以及其使用方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1247109C (zh) | 2006-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6051236A (en) | Composition for optimizing muscle performance during exercise | |
CN100502692C (zh) | 一种体力恢复保健食品及其制备方法 | |
JP6096401B2 (ja) | 筋肉の痙攣及び筋肉痛を予防するためのリボースの利用 | |
CN105454967A (zh) | 一种减缓运动疲劳或提高运动能力的组合物及其运动饮料 | |
CN102448452A (zh) | 用于支持糖尿病治疗的包含α-酮酸的膳食补充剂 | |
PT755633E (pt) | Preparacao bifasica | |
CN1247109C (zh) | 一种运动保健食品 | |
CN107348522A (zh) | 一种改善老年人运动系统功能的营养组合物及其制备方法 | |
CN110801018A (zh) | 辅酶q10维生素c运动含片 | |
EP1555897B1 (en) | Ergogenic multivitamin-mineral energy supplement for the prevention of muscle fatigue | |
CN109475513A (zh) | 提升运动能力的能量组合物 | |
RU2723950C1 (ru) | Фармацевтическая композиция для парентерального капельного введения | |
CN101331950B (zh) | 一种提高运动爆发力的营养补剂 | |
RU2529155C1 (ru) | Шоколад для спортивного питания "шокоспорт" | |
CN100369616C (zh) | 灵芝精华液 | |
CN1823817A (zh) | 一种电解质营养强化剂 | |
TW201117736A (en) | Compositions for sport supplement | |
CN102114066B (zh) | 一种缓解体力疲劳的药物组合物 | |
CN104800826A (zh) | 维微肽含片 | |
CN110584117A (zh) | 一种体力恢复剂及其制备方法 | |
Maughan | Physiology of sport | |
CN101258935A (zh) | 螺旋藻保健品 | |
CN1459289A (zh) | 一种保健食品 | |
CA3224861A1 (en) | Compositions containing adenosine triphosphate (atp) and methods of use for cognitive function | |
Karmakar | Nutrition and periodon |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: SYSCAN MICRO PHOTOELECTRIC TECHNOLOGY (SHENZHEN) Free format text: FORMER OWNER: PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO., LTD., SHIJIAZHUANG PHARMACEUTICAL GRO Effective date: 20050204 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20050204 Address after: 050051 No. 276 West Zhongshan Road, Hebei, Shijiazhuang Applicant after: Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. of CSPC Group Address before: 050041 No. 47 Harvest Road, Hebei, Shijiazhuang Applicant before: Pharmaceutical Technology Development Co., Ltd., Shijiazhuang Pharmaceutical Gro |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Weisheng Pharmaceutical (Shijiazhuang) Co., Ltd. Assignor: Zhongqi Pharm Tech (Shijiazhuang) Co., Ltd., Shiyao Group Contract fulfillment period: 2008.12.8 to 2021.3.29 Contract record no.: 2008130000148 Denomination of invention: Sports health care food Granted publication date: 20060329 License type: Exclusive license Record date: 20081209 |
|
LIC | Patent licence contract for exploitation submitted for record |
Free format text: EXCLUSIVE LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2008.12.8 TO 2021.3.29; CHANGE OF CONTRACT Name of requester: SHIYAO GROUP WEISHENG PHARMACEUTICAL ( SHIJIAZHUAN Effective date: 20081209 |
|
EC01 | Cancellation of recordation of patent licensing contract | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: CSPC Weisheng Pharmaceutical (Shijiazhuang) Co., Ltd. Assignor: Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. of CSPC Group Contract record no.: 2008130000148 Date of cancellation: 20170608 |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170707 Address after: 225300 No. 816, drug city road, Jiangsu, Taizhou Patentee after: Shijiazhuang Pharmaceutical Group Pharmaceutical (Taizhou) Co., Ltd. CHINO Address before: 050051 No. 276 West Zhongshan Road, Hebei, Shijiazhuang Patentee before: Shijiazhuang Pharmaceutical Group Zhongqi Pharmaceutical Technology Co., Ltd. [Shijiazhuang] |
|
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20060329 |